Affiliation:
1. IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE
Abstract
We report a case of a 28-year-old female who had the clinical manifestation of Neuromyelitis optica spectrum disorders with the area postrema syndrome at 24 years old. The patient presented with decreased vision due to acute optic neuritis, gait impairment, tetraplegia, sensory, and bladder disturbances. Magnetic resonance imaging of the spinal cord showed longitudinal high-intensity signals on a T2-weighted image in cervical and thoracic parts. Her serum and cerebrospinal fluid were positive for the anti-AQP4 antibody. The patient received high-dose methylprednisolone, plasmapheresis, but she remained free from relapses only after prescribing Rituximab.
Prophylactic treatment of Neuromyelitis optica spectrum disorders recurrence must be immediately performed when it is identified because the progression of disability is related to the severity of attacks.
Reference43 articles.
1. 1. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F. et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007; 6:805–815.
2. 2. Wingerchuk D.M., Hogancamp W.F., O’Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999; 53:1107–1114.
3. 3. Wingerchuk D.M., Banwell B., Bennett J.L., et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177.
4. 4. Quek A.M.L., Mckeon A., Lennon V.A. et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch. Neurol. 2012; 69:1039–1043.
5. 5. Derle E., Güneş H.N., Konuşkan B., Tuncer Kurne A. Neuromyelitis optica in children: A review of the literature. Turk J Pediatr. 2014;56:573.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献